Genomics Hub Genotypic positions itself as a genomics technology hub in India with aspirations to become a global leader. Sales opportunities include partnerships, technology licensing, and collaboration deals with research institutes and biotech firms seeking advanced sequencing, arrays design, and large-scale genomics projects.

Clinical & Diagnostics Active involvement in developing antigen and antibody kits for COVID-19 suggests a capability and interest in clinical diagnostics. Target opportunities include contract development and manufacturing, assay validation services, and supply partnerships with hospitals, diagnostics distributors, and public health programs.

Certified Capabilities ISO 9001:2015 accreditation and Agilent genomics certification highlight process quality and instrumentation expertise. Leverage these credentials to pursue enterprise clients requiring validated workflows, quality assurances, and compliant services in genomics, translational research, and regulated environments.

NGS & Platform In-house Genomics Lab with Ion Torrent, SOLiD, NextSeq, MiSeq, and sequencing capabilities combined with microarray and bioinformatics units indicate strong end-to-end service scope. Prospect opportunities include targeted resequencing, custom array design, data analysis, and turnkey genomics projects for pharma, agrigenomics, and academic consortia.

Growth & Partnerships Funding from promoters and angels, ongoing expansion ideas, and associate companies in agrigenomics and diagnostics point to a collaborative growth model. Pursue co-development, equity partnerships, and joint ventures with biotech startups, CROs, and research groups seeking to scale genomics solutions internationally.